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The aim of the present investigation was to prepare and characterize lecithin spherulites as parenteral drug sequestering agents with potential
application in the treatment of drug overdose and chemical poisoning. The spherulites (∼200 nm) obtained by controlled hydration and shearing
of lipid–alcohol mixtures, revealed unexpected differences in the physical properties of the bilayer when compared to liposomes. Differential
scanning calorimetry, 31-phosphorus nuclear magnetic resonance, and pH-sensitive pyranine steady-state fluorescence studies indicated that
although spherulites retained the typical bilayer conformation, the arrangement of the phospholipid molecules was perturbed relative to native
liposome bilayer. The loosened packing of the phospholipids in bilayers was strongly supported by the relative ease with which spherulites lost
the established pH-gradient. This permeability problem was overcome via incorporation of cholesterol in the bilayer. Subsequently, albumin/
buffer components were encapsulated in these spherulites and the drug sequestration potential for detoxification application was examined.
Citrate pH-gradient spherulites accumulated 75% of external haloperidol while those loaded with ∼20% (w/w) albumin were able to take up
45% of haloperidol and 91–95% of taxanes (docetaxel and paclitaxel). In cytotoxicity studies, the competitive internalization of docetaxel by
albumin-loaded spherulites resulted in an increase of the IC50 value for the free drug. Thus, the spherulite technology could be a versatile
approach for actively sequestering toxins in the blood and for reducing the adverse effects by altering the pharmacokinetics and biodistribution
of overdosed drugs.
© 2006 Elsevier B.V. All rights reserved.Spherulite; Detoxification; Uptake; Haloperidol; Taxanes1. Introduction
In the recent years, toxic exposure to drugs has become a
serious concern in the western world. For example, deaths
resulting from prescribed-drug poisoning are currently recog-
nized as a growing problem in the United States [1,2]. In Canada,
approximately 8% of hospitalizations were documented for
detoxification treatment following substance abuse [3]. While
there are several widely-used and non-specific remedies for such
emergencies, such as the administration of activated charcoal,
cathartics, diuretics and emetics, none of them can satisfactorily
counter the systemic effects of toxins in a rapid manner. In
contrast to the non-specific methods of detoxification, specific
antidotes act directly by counteracting the chemical toxins and⁎ Corresponding author. Tel.: +1 514 343 6455; fax: +1 514 343 6871.
E-mail address: Jean-Christophe.Leroux@umontreal.ca (J.-C. Leroux).
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doi:10.1016/j.bbamem.2006.08.005their adverse effects in the body. However, the use of an antidote
approach is invariably based on the prior availability of
information on the precise nature of the toxin and its mechanism
of action. Hence, in view of these limitations there is clearly a
need for a versatile and fast-acting approach for reducing the
blood and tissue toxin levels of the intoxicated patient. This
report describes the application of colloidal particulates in the
non-specific detoxification of overdosed drugs.
The idea consists in administering long-circulating particu-
late colloids shortly after intoxication, which would reduce the
bioavailable drug concentration in the body by acting as a sink
for toxins. Since it is only the free form of drug that is
responsible for toxicity, captured molecules would be unable to
exert the toxic effects. Colloids with long-circulating properties
can maximize the sequestration and shift the equilibrium
towards the central compartment in the body to reduce the
tissue levels of toxin (Fig. 1). The application of colloidal
Fig. 1. Pictorial representation of events associated with the chemical intoxication in overdose-cases and the proposed mechanism of action for spherulites. The shaded
areas represent the level of drug tissue burden and toxicity following exposure. After exposure, the toxic substance circulating in the blood is free to diffuse into the
tissue compartments (a). Administration of spherulites with sequestering potential reduces the free levels of drug in the blood, and consequently, causes the release of
tissue-associated substance and its redistribution, thereby alleviating its toxicity (b). Key: ● free toxin; spherulite-sequestered toxin.
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momentum with the use of liposomes containing encapsulated
chelating agents or enzymes. In the simplest form, liposomes
containing chelating agents have been employed to complex
metal ions like cadnium [4] or plutonium [5,6] On the other
hand, pH-gradients have been used for the selective accumula-
tion of ionizable molecules in lipid vesicles [7]. Other
applications involved microencapsulated urease to lower the
systemic urea concentration [8]. Furthermore, the initial attempt
to antagonize the toxic effects of paraoxan pesticide [9], based
on the use of erythrocytes containing the recombinant enzyme
phosphotriesterase was subsequently refined by Petrkovics et al.
[10], by replacing the erythrocytes with sterically stabilized
liposomes. Other recently published investigations for detox-
ification purposes comprised the use of oligochitosan deriva-
tives bearing electron deficient aromatic rings in the
complexation of amitriptyline via π–π interactions [11], as
well as nanocapsules with a hexadecane core and a cross-linked
polysiloxane/silicate shell for bupivacaine sequestration [12].
In this work, spherulites, a particular type of multilamellar
phospholipid vesicles were selected as drug sequestering
colloids. These multilamellar spherulites differ from liposomes
in that they possess rather more uniformly and closely spaced
concentric bilayers of amphiphiles alternating with layers of
aqueous medium. Unlike liposomes, spherulites are generally
obtained through controlled hydration of sheared lipid/surfac-
tant lamellar phases [13,14]. The unique preparation process
imparts them with superior entrapment efficiencies compared to
conventional unilamellar and multilamellar liposomes [15,16].
Owing to their onion-structure and constant interlamellar
distances, such vesicles were anticipated to perform at least as
well as liposomes in terms of the release and protection of
encapsulated substances. Unfortunately, the fact that their
stability was limited by the undesired permeability of surfactantbilayers recently came to light [14,17]. To circumvent this
problem, more complex systems have been designed, such as
the dispersion of spherulites in an oil to provide an additional
barrier and reduce the diffusion of molecules [18]. However,
these multiple w/o/w emulsions also suffered from stability
drawbacks due to the expulsion of spherulites from the oil
phase. In the present investigation, an attempt was made to
prepare surfactant-free biocompatible and biodegradable spher-
ulites, and their sequestration capabilities were fortified either
by providing a pH-gradient or by encapsulating albumin in the
presence of cholesterol (CHOL). Albumin, a major blood
protein, is known to bind several classes of drugs due to a
variety of physical interactions. Its affinity generally increases
with the hydrophobicity of the molecule. This protein could be
exploited in entrapped form to maximize the spherulites
sequestration capabilities without causing significant alteration
in the blood osmotic pressure following intravenous injection.
Since pharmaceutical preparations containing albumin (Abrax-
ane™, Buminate™) are currently marketed for parenteral
administration, a safe clinical application of these spherulites for
non-specific detoxification purposes could be speculated.
The purpose of this work was to evaluate the potential of
using spherulites as drug detoxicants. Sequestration was studied
in vitro for three drugs, namely haloperidol, docetaxel, and
paclitaxel. The mechanical and permeability properties of the
spherulites were modulated by varying the bilayer CHOL
concentration. Albumin-loaded and pH-gradient spherulites
were prepared in order to maximize the drug uptake into the
vesicular aqueous compartments. To understand the bilayer
organization and permeability, the spherulites were analyzed by
differential scanning calorimetry (DSC), spectrofluorimetry, and
phosphorus nuclear magnetic resonance (31P-NMR) spectro-
scopy. Finally, the drug-sequestration potential of the spherulites
was demonstrated by cytotoxicity assay for docetaxel.
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2.1. Materials
Phospholipon 90 G (98% soya phosphatidylcholine, SPC) was a gift from
Rhône-Poulenc Rörer (Köln, Germany). Distearoyl phosphatidyl ethanolamine
polyethylene glycol 2000 (DSPE-PEG2000) and CHOL were purchased from
Northern Lipids Inc. (Vancouver, BC, Canada). 3H-labelled haloperidol
(12.8 Ci/mmol) was from Perkin Elmer (Woodbridge, ON, Canada). 14C-
labelled docetaxel (60 mCi/mmol) and 3H-labelled paclitaxel (60 Ci/mmol)
were obtained from American Radiolabeled Chemicals Inc. (St. Louis, MO).
Paclitaxel was purchased from Bioxel Pharma Inc. (Sainte-Foy, QC, Canada).
Docetaxel was provided by Shanghai Fudan Taxusal New Technology Co.
(Shanghai, China). Haloperidol, bovine serum albumin (BSA), (±)-α-
tocopherol, pyranine, ferric nitrate, deuterium oxide, ammonium thiocyanate,
o-phthaldialdehyde, praseodymium nitrate and 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl-tetrazolium bromide (MTT) were procured from Sigma-Aldrich
(Oakville, ON, Canada). BCA® reagent and 30% solution of N,N′bis-
methylene acrylamide were purchased from Pierce (Rockford, IL) and BioRad
(Hercules, CA), respectively. Dulbecco’s modified Eagle’s medium, foetal
bovine serum (FBS) and antibiotic were from Invitrogen Corp. (Grand Island,
NY). Franz diffusion cells and membrane filters were purchased from Cole
Parmer (Vernon Hills, IL) and Avestin (Ottawa, ON, Canada), respectively. All
other chemicals and solvents were of reagent grade. Water was deionized with
a MilliQ purification system (Millipore, Bedford, MA) before use.
2.2. Preparation of vesicles
2.2.1. Preparation of spherulites
Spherulites were prepared by the shearing of the lamellar phase [17,19], using
an in-house fabricated apparatus which was comprised of a stainless steel cup
(shear cell) and a shear head. A shear-gap of 1 mm was maintained between the
cup and rotor head. The cup was mounted into a module with water jackets to
maintain the desired temperature. Typically, SPC (200 mg) and CHOL (10–
50 mg) were weighed into the shear cell, and 30% (w/w) ethanol containing 10%
(w/w) glycerol was added. Then, the rotor head was placed in the cup and rotated
at 150 rpm to dissolve the lipids in ethanol at 45 °C. For the incorporation of
tocopherol or PEG-DSPE, the excipient was included along with the SPC/CHOL
mixture before hydration. The lipid phase was slowly hydrated by the addition of
50 mMphosphate buffered saline (PBS) at pH 7.4 (adjusted to 308mOsm/L with
NaCl) containing or not BSA (50% w/v), or 100 mM citrate/75 mM phosphate
buffer pH 3.0 (adjusted to 308mOsm/Lwith NaCl) under shear. The formation of
lyotropic lamellar phase with birefringent properties was confirmed by polarized
light optical microscopy (Axioskop 40, Carl Zeiss Canada, Kirkland, QC,
Canada). For this, a small quantity of the sheared sample was placed on a glass
slide, covered with a cover-slip and observed through crossed polarizers at a
magnification of 100×. Digital images of the samples were acquired using
MicroPublisher 3.3RTV camera and processed with Image ProPlus™ (version
5.0) software (Q-Imaging Inc., Burnaby, BC, Canada). To obtain spherulites, the
lamellar phase was gradually diluted with the buffer under shear, which was
finally passed through a 0.45-μm membrane filter to remove any lipid particles.
Free albumin was removed by dialyzing the formulation against 0.5 L of PBS
buffer for 7 days (dialyzing buffer changed every 24 h) at 4 °Cwith stirring, using
100-nm pore size polycarbonate membranes (Millipore). The phospholipid,
CHOL and albumin content were assayed by colorimetry using the ferric-
ammonium thiocyanate [20], phthaldialdehyde [21] and BCA™ protein assay
reagents, respectively.
2.2.2. Preparation of liposomes
Liposomes were prepared by the film hydration method [22]. Typically,
SPC along with other components were dissolved in a mixture of
chloroform:methanol (2:1 v/v) and the lipid film obtained by rotary-
evaporation was subjected to an additional period of vacuum for 12 h.
Subsequently, the film was hydrated with the required buffer to obtain the
multilamellar liposomes of the desired lipid concentration. To prepare
unilamellar liposomes, the multilamellar vesicles were extruded through
polycarbonate 0.2-μm membrane filter (LiposoFast extruder, Avestin,
Ottawa, ON, Canada) at room temperature.2.3. Size measurements
The mean diameter and size distribution were determined by dynamic light
scattering in back scattering mode with a Nano-ZS Zetasizer (Malvern
Instrument Ltd., Malvern, Worcestershire, UK). CONTIN program was used
to extract the size distributions from the auto-correlation functions.
2.4. Gel electrophoresis
Chemical stability of the encapsulated albumin was determined by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Molecular
weight markers, albumin standards and spherulite–protein samples were
reduced prior to loading on 7.5% resolving PAGE by the standard method
[23]. The separated bands were stained with Coomassie blue, scanned under
trans-illuminating white light using MultImage™ plate reader, and analyzed by
ChemImager™ 5500 software (Alpha Innotech Corp., San Leandro, CA).
2.5. DSC studies
Thermal scans were acquired for the liposomes and spherulites suspended in
0.9% (w/v) NaCl to reveal any differences in the bilayer organization.
Calorimetric measurements were carried out using DSC 2910 calorimeter (TA
Instruments Inc. New Castle, DE), calibrated with indium. Samples placed in the
aluminum pans were sealed with a lid having pin holes. They were cooled at
5 °C/min to −50 °C, held isothermally for 30 min and heated at 2 °C/min to
80 °C under a flow of helium. All data were analyzed using TA Universal
Analysis software version 2.5 H.
2.6. 31P-NMR analysis
Extruded liposomes and spherulites of similar sizes (180–210 nm) were
prepared in 0.9% NaCl as described in section 2.2 to obtain a final lipid
concentration of 50 mg/mL. 31P-NMR spectra were recorded on a Bruker
Avance 300 spectrometer (Bruker, Billerica, MA) operating at 121.45 MHz in a
5-mm broad band probe with proton decoupling at 25 °C, as previously reported
[24]. Each sample was suspended in 10% D2O and 5000–5200 transients were
accumulated with a pulse length of 14 μs and 1 s relaxation delay. The free
induction decays were processed using an exponential line broadening of
100 Hz prior to Fourier transformation. To obtain information on the distribution
of phospholipid molecules, measurements were also performed with 7.5 mM
praseodymium nitrate (PrNO3) as shift reagent.
2.7. pH-gradient stability studies
For the measurement of relative stability of trans-membrane pH-gradients of
both liposomes and spherulites, fluorescent properties of entrapped pyranine
were monitored. Extruded liposomes and spherulites containing pyranine were
prepared by the methods described in Section 2.2 using a citrate hydration buffer
(10 mM, pH 3.0, adjusted to 308 mOsm/L with NaCl) containing 5 mM
pyranine. To remove the free dye from the extravesicular bulk phase as well as
generate a pH-gradient, the preparations were dialyzed against 50 mMphosphate
buffer (pH 8.0, adjusted to 308 mOsm/L with NaCl). Dialysis was performed at
4 °C (100-nm pore size membrane) with the dialyzing medium replaced every
12 h for 4 days. Prior to fluorescence measurements, lipid suspensions were
diluted with pH 8 PBS to a final lipid concentration of 0.5 mg/mL. Excitation
scans were obtained on an AMINCO Bowman™ Spectrofluorimeter (Thermo
Spectronic Instruments, Rochester, NY) at an emission wavelength of 520 nm
with slit width of 2 nm. All formulations were stored at 4 °C and measurements
were performed at 5 °C to minimize the flux across membrane.
2.8. In vitro drug uptake studies
The uptake of haloperidol, docetaxel or paclitaxel into spherulite/liposome
formulations was determined by following the time course of drug transfer from
the donor to the acceptor compartment using jacketed Franz diffusion cells.
During the uptake studies, the temperature was maintained at 37±0.2 °C using a
circulating water bath and cells were continuously stirred at 600 rpm. The
Fig. 2. Polarized light optical microscopy of spherulites (magnification 100×)
prepared in the presence of ethanol showing a large number of Maltese crosses
in the sheared sample. The characteristic birefringent texture was observed for
all spherulite formulation.
Fig. 3. SDS-PAGE data of spherulites with (+) and without (−) entrapped BSA.
Key: Spherulites without CHOL (a), with CHOL (b), and with CHOL and 5 mol
% DSPE-PEG (c, d).
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mL 3H/14C-labelled drug. Prior to the set-up of the diffusion cells, both the
membrane and O-rings were incubated in drug-containing PBS (pH 7.4). Then,
the required quantity of formulation (500 μL, pH 7.4) was introduced into the
lower compartment through the side port. The donor (sampling) compartment
was physically separated from the acceptor compartment containing formulation
by a 50-nm pore diameter membrane. At the zero time point, the volumes in the
sampling and acceptor compartments were adjusted to 0.8 and 4.8 mL,
respectively, to ensure the same drug concentration in both compartments. At
pre-determined time intervals, 20-μL aliquots were withdrawn from the sampling
compartment, mixed with 5 mL of UltimaGold™ and analyzed by radioactivity
counting. The rate of disappearance of drug from the sampling compartment was
plotted as a function of time and correlated to the drug uptake.
2.9. Cell culture experiments
Cytotoxicity studies were performed on B16F10 cancer cells to assess the
uptake of docetaxel into albumin–spherulites by the MTT proliferation assay
[25]. B16F10 melanoma cell-line was obtained from the American Type Culture
collection (ATCCRockville,MA) and grown in the Dulbecco's modified Eagle's
medium supplemented with 10% FBS and 1% (w/v) penicillin–streptomycin in a
humidified atmosphere at 37 °C with 5% carbon dioxide in air. After the cells
reached 85–90% confluence, they were trypsinized and seeded in 96-well plates
at a density of 1000 cells/well. They were allowed to adhere for 24 h, and the
medium in wells was replaced with 100 μL of fresh medium containing
increasing concentrations of docetaxel (0.1–100 nM). An equal quantity of either
saline or spherulites suspended in salinewas added, and the plates were incubated
at 37 °C for 15 h. After treatment, the contents of each well were removed by
aspiration. 100 μL of fresh medium and was added and the cells were allowed to
grow for 48 h. At the end of this period, MTT reagent (10 μL of 5 mg/mL) was
added; the formazan produced was solubilized by the addition of 100 μL of 15%
(w/v) SDS in 0.01 N HCl and the absorbance was measured at 470 nm with a
Safire™ plate reader (Tecan Austria GmbH, Salzburg, Austria).
3. Results
3.1. Preparation of spherulites
In this report, spherulites were prepared from phospholipids
dissolved in ethanol containing 10% (w/w) glycerol in the
absence of any surfactant. This finding should be beneficial
from the formulation point-of-view since many surfactantsapproved for parenteral use are not completely free from side-
effects. Thus, the absence of surfactants would allow the
administration of large quantities of phospholipid spherulites in
the clinical setting while dealing with heavily intoxicated
subjects. Shearing of SPC-ethanol lamellar phase under
controlled hydration at 45 °C yielded spherulites with an
average diameter of 200 nm (polydispersity index <0.25).
When examined by polarizing microscopy, the concentrated
phase of spherulites contained a polarization cross with the arms
parallel to the plane of polarization, indicating that the
molecules were arranged in layers (Fig. 2).
Spherulite formulations loaded with BSA (a surrogate for
human albumin) were prepared to maximize the sequestration
properties of the vesicles. For the spherulites having a lipid
membrane composition of SPC/CHOL ratio 200/10, 200/30 and
200/50 (w/w), the BSA loadings reached 1.7, 13.1 and 19.6%
(w/w), respectively. In addition to the membrane composition,
other factors that were studied included, shearing temperature
and pH. Increasing the shearing temperature from 45 to 50 °C as
well as reducing the pH from 7.4 to 4.7 (iso-electric point of
albumin) did not improve the entrapment of BSA (data not
shown). SDS-PAGE stability studies showed that the entrapped
albumin was protected from degradation in all formulations and
remained chemically intact after storage at 4 °C for at least
15 days (Fig. 3).
In the past, investigations were focused on the preparation of
spherulites either from surfactant or phospholipids+surfactant
bilayers and the published literature showed no report where
spherulites were obtained from 100% lecithin. Due to these
differences, it was pertinent to understand the molecular
organization of the system. Lipid molecules could, in fact,
organize into novel arrangements which would have a direct
impact on their performance. Hence, the membrane properties
Fig. 4. DSC traces of liposomes (solid lines) and spherulites (broken lines)
during the heating phase of a cool–heat cycle. The endotherms were recorded at
a heating rate of 2 °C/min. All formulations were suspended in saline and were
in the size range of 180–210 nm. Key: (a) SPC/CHOL=200/50, (b) 200/30, (c)
200/0 (w/w).
Fig. 5. 31P-NMR spectra for liposomes (a), spherulites (b) and BSA-loaded
spherulites (c). All formulations were suspended in saline and were in the size
range of 180–210 nm. Scale in ppm. Key: Top: SPC/CHOL 200/0, middle: 200/
30, bottom: 200/50 (w/w).
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and pyranine-fluorescence studies.
3.2. DSC studies
DSC is an extensively investigated, sensitive, and non-
perturbing tool used to study the thermotropic phase
transitions of lipid membranes. Lipid bilayer vesicles display
a number of phase transitions of which, the gel-to-fluid
transition, characterized by a disordering of the acyl chains, is
especially diagnostic of membrane organization. This transi-
tion is generally observed for the unsaturated phospholipids
below the freezing point of water (Fig. 4). Upon heating, the
control extruded liposome formulations exhibited the main
phase transition (Tm) at −20.3, −19.7 and −19.6 °C for
formulations with SPC/CHOL ratios of 200/0, 200/30 and
200/50, respectively. On the other hand, for the same sequence
of lipid ratios, spherulites displayed lower Tm at −22.4, −22.3
and −22.6 °C, respectively. Liposomal bilayers exhibited a
relatively sharp and symmetric endothermic peak while that of
spherulites was asymmetric and broad. The peak widths at
half-height were in the range of 1 to 1.5 and 2.3 to 2.8 °C for
liposomes and spherulites, respectively. As shown in Fig. 4,
the variation of heat flow associated with the gel-to-liquid
crystalline transition decreased progressively in intensity with
higher CHOL content. Thus, CHOL seemed to be inserted in
the spherulite bilayers while exerting an effect similar to
that in the liposomes. Furthermore, DSC studies revealed that
ΔT1/2 and Tm were essentially the same for BSA encapsulated
spherulites as that for albumin-free spherulites (data not
shown).
3.3. 31P-NMR analysis
31P-NMR spectroscopy provides valuable information on
the organization of lipid bilayer vesicles due to the sensitivity ofthe conformation and dynamics of the phosphate nucleus with
respect to the surrounding environment. All formulations
showed a spectrum shape intermediate to an isotropic and
powder pattern, typical of phospholipid vesicles with a
hydrodynamic radius around 200 nm (Fig. 5) [26–28]. The
low intensity isotropic signals (0 ppm) superimposed on the
regular powder patterns could be attributed to the presence of
tiny, rapidly tumbling vesicles or could be associated with other
Fig. 6. Fluorescence excitation spectra of encapsulated pyranine in liposomes
(a) and spherulites (b). Pyranine was encapsulated in formulations at internal
pH 3.0 citrate buffer and dialyzed against pH 8 buffer for 4 days at 4 °C prior to
the acquisition of the spectra. Note the differences in the intensity of the
excitation peak at 405 nm (indicated by arrows). See text for detailed
explanation. Key: (△) SPC; (♦) SPC/Tocopherol: 200/22; (○) SPC/CHOL:
200/50 (w/w).
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NMR time scale. Compared to liposomes, the 31P-NMR spectra
of spherulites were systematically closer to powder patterns.
This trend was observed for all formulations investigated,
independent of CHOL content. CHOL had little effect on the
spectra of liquid-crystalline bilayers, as previously observed
[29]. To investigate the possibility that albumin could interfere
with spherulite formation, 31P-NMR analysis was also
performed on BSA-loaded spherulites at various lipid to
CHOL ratios (Fig. 5c). The resulting NMR spectra were similar
to those obtained without BSA. This indicates that the
spherulites could encapsulate albumin both in the presence
and absence of CHOL, without any significant perturbation of
the bilayer structure.
The ratio of phospholipid molecules on the outside to that on
the inside of vesicles (i.e. lamellarity), was determined by
relative peak area after shifting the exterior phosphate
resonances downfield (∼30 ppm) by the addition of 7.5 mM
Pr3+(Table 1). For liposomes, the area ratio between the signal
of the outer to inner (O/I) monolayers ranged between 0.46 and
0.51. Spherulites exhibited a lower O/I ratio, ranging from 0.35
to 0.37 in the absence of BSA, suggesting an increased
lamellarity. From Table 1, it is also observable that the O/I ratio
decreases following the entrapment of albumin in CHOL-
containing vesicles.
3.4. pH-gradient stability studies
A number previously published reports have demonstrated
the uptake of basic drugs into liposomes bearing an acidic intra-
vesicular pH environment [30–32]. With time, the established
pH-gradients can gradually dissipate due to the exchange of
protons and counter-ions across the bilayer. This leads to a loss
in the efficiency of internalization of those drugs whose transfer
is pH-gradient driven. Thus, monitoring the pH-gradients across
bilayers provides an indication of the performance of the
formulation and an assessment of its stability. Pyranine is a pH-Table 1
31P-NMR O/I ratios for SPC liposomes and spherulites in the presence of
7.5 mM Pr(NO)3 shift reagent













Mean vesicle diameter and polydispersity index were 200 nm and 0.25,
respectively.
a Ratio of external to internal phospholipid molecules.sensitive fluorescent acidic probe (pKa ∼7.22) which has been
explored for steady state measurements when trapped within the
aqueous interiors of vesicular systems [33]. In the excitation
spectra, λmax at 405 and 450 nm are assigned to the unionized
and ionized forms of pyranine, respectively [34].
Pyranine was entrapped in both liposomes and spherulites of
varying membrane compositions at an internal pH of 3. The
vesicles were challenged against an external pH of 8 for 4 days,
after which the fluorescence spectra were monitored. Figs. 6a
and b show the excitation spectra of entrapped pyranine for
liposomes and spherulites, of which the membrane constitution
was either SPC alone, SPC/tocopherol (200/22) or SPC/CHOL
(200/50). Since peroxidized bilayers are known to be highly
leaky, tocopherol was also incorporated in the bilayers to find out
if lipid peroxidation was a major factor in promoting the
permeability of spherulites prepared at 45 °C [33]. All liposomal
formulations, irrespective of their composition, exhibited a
distinct peak at 405 nm in the excitation spectra which
corresponds to the unionized pyranine species. This peak was
of lower intensity in the SPC and SPC/tocopherol spherulites,
indicating the low unionized/ionized ratios for entrapped
Table 2
Emission ratios a (Em450/405) of entrapped pyranine in pH-gradient
b liposome
and spherulite formulations after a 4-day dialysis period
Formulation Em450/405 ratio
SPC SPC/tocopherol SPC/CHOL
Liposomes 1.13 1.41 1.25
Spherulites 1.76 1.76 1.20
a The ratios were obtained from excitation spectra. A high Em450/405 ratio
indicates a high ionized/unionized ratio for pyranine.
b 100 mM citrate buffer pH 3.0.
Table 4
In vitro uptake of haloperidol by SPC/CHOL spherulites a in albumin-containing













30 0 7.4 − 1 13.2 (2.1)
30 0 7.4 + 1 25.4 (2.8)
50 0 7.4 − 1 18.1 (2.2)
50 0 7.4 + 1 24.7 (2.0)
50 5 7.4 + 1 28.6 (0.8)
50 0 3.0 c − 1 68.1 (1.7)
50 0 3.0 c − 3 53.5 (1.5)
All data are mean, n=4 (SD).
a SPC content was set at 200 mg in all formulations. Mean vesicle diameter
and polydispersity index were 200 nm and 0.25, respectively.
b The uptake studies were conducted at drug and lipid concentrations of
40 ng/mL and 3 mg/mL, respectively.
c Citrate buffer 100 mM.
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CHOL was incorporated into the membrane. The ratios of
emission intensity at 450/405 (Em450/405) is an indicator of the
relative acidic to alkaline shift in pH within the interior of
vesicles following the challenge period [34]. These ratios were
1.13, 1.41, 1.25 and 1.76, 1.76, 1.20 for SPC, SPC/tocopherol,
SPC/CHOL liposomes and spherulites, respectively (Table 2).
The noticeably high Em450/405 values for the spherulites
bearing SPC and SPC/tocopherol compositions indicate a shift
in pH accompanied by neutralization of the acidic compartment.
These results suggest that even at considerably high levels,
tocopherol was not effective in diminishing the permeability and
rules out lipid peroxidation as a major factor for the high bilayer
permeability in spherulites. Further, the Em450/405 ratio of
spherulites was comparable to that of liposomes when CHOL
was incorporated within the bilayer indicating reduced perme-
ability of the bilayer to the flux of ions [32,33].Table 3
In vitro uptake of haloperidol, docetaxel and paclitaxel by SPC/CHOL










10 0 7.4 − 31.0 (1.5)
10 0 7.4 + 31.0 (1.1)
30 0 7.4 − 21.0 (1.6)
30 0 7.4 + 38.6 (3.1)
50 0 7.4 − 18.9 (1.7)
50 0 7.4 + 47.0 (1.6)
50 5 7.4 + 45.4 (0.3)
50 0 3.0 (75 mM phosphate) − 52.5 (1.9)
50 0 3.0 (100 mM citrate) − 75.2 (1.3)
Docetaxel
30 0 7.4 − 77.0 (1.4)
30 0 7.4 + 94.4 (2.3)
Paclitaxel
30 0 7.4 − 75.9 (1.4)
30 0 7.4 + 91.5 (1.6)
All data are mean, n=4 (SD).
a SPC content was set to 200 mg in all formulations. Mean vesicle diameter
and polydispersity index were 200 nm and 0.25, respectively.
b Albumin encapsulation was 1.7, 13.1 and 19.6% (w/w) for SPC/CHOL:
200/10, 200/30 and 200/50, respectively.
c Uptake studies were conducted at drug and lipid concentrations of 40 ng/mL
and 3 mg/mL, respectively.3.5. Uptake studies
The relative sequestration capabilities of various formula-
tions were evaluated through uptake studies using the Franz
diffusion cells. Uptake of the weak base haloperidol into
spherulites was monitored during a period of 4 h in the absence
(Table 3) and presence of external albumin (Table 4) or FBS
(Table 5). All formulations exhibited a first-order uptake profile
suggesting that the kinetic process was concentration-gradient
driven. Moreover, these profiles showed no apparent lag time
and a time-of-50% uptake in the range of 20–30 min,
suggesting a rapid drug uptake (data not shown). In the absence
of entrapped albumin, spherulites showed the highest uptake of
haloperidol (31%) when the SPC/CHOL ratio was 200/10
(Table 3). It decreased to 21% and 18.9% at SPC/CHOL ratios
of 200/30 and 200/50, respectively. It is also interesting to note
that, at SPC/CHOL ratio of 200/10, the incorporation of BSA
made no significant contribution to the uptake (p<0.05,
unpaired t-test). This situation was reversed upon entrapment
of BSA at higher CHOL levels (SPC/CHOL 200/30 and 200/
50). A consistent feature of albumin–spherulites was an
enhanced capacity to take up haloperidol as the CHOL content
was increased. (Table 3). It was found that the incorporation of 5
mol% DSPE-PEG2000 (a lipid used to prolong the circulation
times of lipid vesicles) into SPC/CHOL 200/50 spherulites, had
no impact on the uptake of haloperidol (Table 3). Subsequent
attempts with pH-gradient SPC/CHOL 200/50 spherulitesTable 5
In vitro uptake of haloperidol into SPC/CHOL (200/50) pH-gradient a liposomes
and spherulites in the absence and presence of FBS at 37 °C
Formulation Uptake b (%)
No FBS 50% FBS
Multilamellar liposomes 69.5 (1.1) 27.5 (0.8)
Extruded liposomes 70.9 (0.7) 33.4 (0.9)
Spherulites 75.2 (1.3) 38.3 (1.2)
All data are mean, n=4 (SD).
a 100 mM citrate buffer pH 3.0.
b The uptake studies were conducted at drug and lipid concentrations of
40 ng/mL and 3 mg/mL, respectively.
Fig. 7. Survival of B16-F10 cells as a function of docetaxel concentration in the
absence (▴) and presence of 0.75 (■) and 1 mg/mL (●) BSA-loaded spherulites
(SPC/CHOL: 200/50 coated with 5 mol% DSPE-PEG).
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much higher uptake values. They ranged from 52.5 to 75.2%
(Table 3), and were significantly higher than for the albumin-
encapsulated systems (p<0.05, unpaired t-test). Owing to its
basic nature, haloperidol can freely cross the membrane in the
non-ionized state and accumulate in the acidic compartment of
the pH-gradient vesicles.
In order to mimic physiological conditions, the sequestration
of haloperidol into spherulites was evaluated in the presence of
albumin in the external medium (Table 4). For BSA-spherulites,
at 1% external albumin, the uptake was reduced from 38.6 to
25.4%, and from 47.0 to 24.7% at SPC/CHOL ratios of 200/30
and 200/50, respectively. Similar decreases were observed for
BSA-free spherulites. Haloperidol uptake into PEGylated
spherulites also reduced substantially and was comparable to
that of the uncoated formulations. For citrate pH-gradient
spherulites, the competitive effect of external albumin had less
impact on the uptake (Table 4). Additionally, when the stability
of spherulites was assessed, the vesicle size remained unchanged
for at least 2 months after preparation. The uptake of haloperidol
was then re-examined for the pH-gradient spherulites stored
under refrigerated conditions. After a period of 45 days, it
decreased from 52.5% to 42.4% for phosphate pH-gradient
spherulites while it remained unchanged for citrate pH-gradient
spherulites (p>0.05, unpaired t-test). These differences in
stability (phosphate vs. citrate) of vesicles might be due to the
different permeability values for phosphate and citrate ions
across the bilayers.
The capture of haloperidol by spherulites (pH 3, citrate
gradient) was then compared to multilamellar (780 nm) and
extruded (180 nm) liposomes of identical membrane composi-
tion (SPC/CHOL 200/50) (Table 5). These pH-gradient
liposomal formulations showed uptake values of 69.5 and
70.9%, respectively, in PBS. When 50% FBS was added to the
medium, the uptake values were lowered by 60, 53, and 49%,
for multilamellar liposomes, extruded liposomes, and spher-
ulites, respectively. The higher uptake by spherulites (p<0.05,
ANOVA), both in the presence and absence of FBS may be
attributed to a higher encapsulation of citrate buffer thereby
contributing to the higher net sequestration of haloperidol.
Finally, the uptake of the non-ionizable drugs, docetaxel and
paclitaxel was examined into BSA-spherulites. pH-gradient
spherulites were not employed in this case because of the neutral
character of these drugs. Due to the highly hydrophobic nature
and affinity for bilayers, the sequestration of taxanes was higher
than that of haloperidol for a given composition of spherulites.
Drug uptake at a SPC/CHOL ratio of 200/30 was 77.0% for
docetaxel and 75.9% for paclitaxel. Upon entrapment of
albumin, these values increased to 93.7 and 91.5%, respectively
(p<0.05, unpaired t-test, Table 3). Clearly, the incremental
uptakes could be attributed to the presence of albumin and its
binding property which was not altered during formulation.
3.6. Cytotoxicity studies
To complement the in vitro uptake data, cell viability studies
were conducted on docetaxel-sensitive melanoma cells either byexposing the cells to the free drug alone or the free drug in the
presence of spherulites. PEGylated BSA-spherulites were
chosen in view of the slightly higher uptake observed for
haloperidol in an albumin environment, as well to minimize the
interaction between the vesicles and the cells. A significant
decrease in the cytotoxicity of docetaxel was noted when the
cells were exposed to the drug in the presence of albumin-
loaded PEGylated spherulites made of SPC/CHOL 200/50 (Fig.
7). The calculated IC50 value for docetaxel alone was 5.2 (±1.0)
nM, while it increased to 8.0 (±1.1) and 14.0 (±2.5) nM in the
presence of 0.75 and 1 mg/mL spherulites, respectively
(p<0.01, ANOVA). The higher viability of cells at higher
spherulite concentrations clearly implies a fall in the levels of
free drug in the culture medium due to the partitioning of
docetaxel into the spherulites.
4. Discussion
An interesting aspect associated with the shearing of
lyotropic lamellar phase comprise phospholipid and surfactant
mixtures is the formation of well organized lamellar structures
called spherulites [14,15]. Spherulites have been proposed as an
alternative to liposomes for achieving higher entrapment of
water-soluble molecules [13–15,17]. During pre-formulation
investigations, we discovered that bilayers containing surfac-
tants were highly leaky. In an attempt to produce surfactant-free
spherulites, ethanol was found to be a viable option. Lipids
dissolved in ethanol formed spherulites upon controlled
hydration and shear. Ethanol was subsequently eliminated
from the formulation by dialysis. These surfactant-free
spherulites, which are expected to possess a toxicological
profile similar to phospholipid liposomes, were further explored
for application to detoxification purposes.
The spherulites were examined by DSC and compared to
extruded liposomes of similar size. The observed differences in
thermal transition events, i.e. a shift in Tm and a broadening of
the transition profile, could be ascribed to a loss of cooperativity
[35,36]. During the phase transition, the melting process is a
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thus gives rise to a sharp peak in the DSC thermogram.
However, when the cooperativity is disturbed due to perturba-
tion in the packing of the bilayer, the lipid acyl chains undergo a
more gradual disordering, which leads to the broadening of the
phase transition. Steady-state fluorescence measurements with
entrapped pyranine also revealed that under similar conditions,
spherulites devoid of CHOL failed to maintain an established
pH-gradient, while liposomes were successful. Hence, the
increased permeability of the bilayer confirmed the perturba-
tions in the packing of the spherulite membrane. In addition to
the changes in Tm, the subtle differences in
31P-resonance peak
profiles between spherulite bilayers and liposomes could be
attributed to decreased vesicle tumbling rates. These were likely
caused by the larger lipid mass contained in spherulites. The
proposed loosened packing of lipid molecules in spherulites
may be related to (i) an osmotic stress imposed on the bilayers
by the non-uniform distribution of entrapped solutes during
lipid organization and hydration, and/or (ii) the presence of
packing defects in the bilayer structure related to the fabrication
of spherulites from sheared lamellar phases [13,33,36,37].
Further studies are needed to verify these hypotheses.
In this work, the application of spherulites for a generalized
and non-specific detoxification approach was verified in vitro by
incorporating albumin or acidic buffers, and by examining the
accumulation of non-ionizable (taxanes) and ionizable (haloper-
idol) molecules. As described above, DSC and fluorescence data
together revealed that lipid acyl chains are loosely packed and
weaker interactive forces prevail in spherulites. Hence, the
rigidizing properties of CHOL on these bilayers were exploited,
and CHOL amounts were systematically varied to improve the
spherulites sequestration capabilities. The condensing effect of
CHOL on the liquid-crystalline phospholipid bilayers results in
tighter molecular packing thereby decreasing the permeability to
hydrophilic molecules and the penetrability of water into the
bilayers [29,38,39]. Since the total quantity of drug sequestered
is a summation of the amount solubilized in the bilayers and the
internal aqueous phase, it is not surprising that the uptake of
haloperidol decreased with increasing CHOL amounts in the
lipid bilayer. The decreased affinity of lipid membranes for
haloperidol with increasing CHOL concentration was pre-
viously studied by Sarmento et al. [40]. They reported a 7-fold
decrease in the apparent partition coefficient for a 1.5-fold
increase in CHOL bilayer content. In contrast, a noticeable
feature of the albumin-spherulites was the higher internalization
of haloperidol with increasing CHOL/SPC ratio. This can be
explained by the physical changes in the bilayer introduced by
the steroid during membrane organization (see NMR data),
consequently increasing the loading of albumin and subsequent
drug sequestration. This hypothesis is supported by the 31P-
NMR experimentation which points out to the increased
lamellarity of albumin-spherulites, and consequently the
entrapment of albumin, as an important effect of CHOL on
these bilayers (Table 1).
A noticeable feature of pH-gradient spherulites is their ability
to take up higher amounts of haloperidol compared to albumin-
spherulites, especially in the medium mimicking the physiolo-gical environment. An indirect evidence in favor of the pH-
gradient spherulite approach can be drawn from a study
conducted with egg phosphatidylcholine/CHOL liposomes
exhibiting a trans-membrane pH-gradient (300 mM citrate, pH
4) [7]. The ability of these liposomes to alter the pharmacoki-
netics of doxorubicin and increase the maximum tolerated dose
in mice correlated well with the uptake under in vitro conditions.
Accordingly, it could be stated that pH-gradient driven potential
is superior to that of the albumin encapsulated system for the
uptake of basic drugs. On the other hand, the formulations based
on the protein encapsulation approach are potentially useful
sequesters for membrane-permeable, non-ionizable toxins
which do not respond to pH such as taxanes. However, it
needs to be mentioned that under in vivo conditions, the
detoxifying properties of albumin-spherulites could be reduced
by the competitive binding of the toxin to the blood components.
Thus, in order for this approach to be successful in the clinic and
for achieving a rapid detoxification action, the albumin-
spherulites would need to be dosed by intravenous infusion at
levels that are required to cause displacement of already bound
drugs in favor of spherulites. In this regard, the countered
inhibitory action of the free drug on cell proliferation by
PEGylated albumin-spherulites, as well as the spherulite dose-
dependent increase in IC50 value of docetaxel in the cytotoxicity
studies, is a fine illustration of their detoxification potential.
Hence, it is anticipated that the specific properties imparted to
the vesicles by PEG and CHOL, namely stealthiness and
membrane rigidity, would collectively reduce their elimination
by the mononuclear phagocyte system in vivo, thereby allowing
the spherulites to circulate long enough to scavenge and
sequester toxins or overdosed drugs.
5. Conclusion
To our knowledge, this is the first demonstration of
application of surfactant-free spherulites as a novel tool in the
armamentarium for poisoning treatment. The sequestration
capabilities of spherulites have been augmented either by the
encapsulation of albumin or by the establishment of a trans-
membrane pH-gradient. The former approach would be a
versatile tool for the internalization of almost any toxin or drug
with affinity for albumin, while the latter formulations would
rapidly respond to basic molecules. It was possible to
substantiate the sequestration capabilities of spherulites by
virtue of their ability to reduce the cytotoxic effects of docetaxel
on cancer cells. Regardless of the fact that spherulites resemble
liposomes in terms of bilayer constitution, dye-entrapment
studies revealed that the bilayers of spherulites are apparently
more permeable than liposomes. In this regard, CHOL was
found to be a suitable membrane component to prevent the
leakage of contents across the inherently permeable spherulite
bilayers. Since the physical properties of bilayers govern the
interaction and movement of molecules across the lipid
membrane, as well as influence the in vivo circulation and
disposition of vesicles, further studies are warranted to better
comprehend these related phenomena and to improve the
therapeutic application of these systems.
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